Arthritis Research & Therapy will publish a new thematic series dedicated to the topic Digital Rheumatology.
Deadline for submissions has been extended to 31st March 2021. Find out more here
Call for Papers: Thematic series on Digital Rheumatology
Articles
-
-
Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis
-
Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients
-
Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
-
Serum biomarker panel for the diagnosis of rheumatoid arthritis
-
Use of NSAIDs in treating patients with arthritis
-
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
-
Degeneration of the intervertebral disc
-
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence
-
Complement and systemic lupus erythematosus
Join our 20th anniversary celebrations by browsing through the journal’s milestone achievements and our specially commissioned Editorial collection.
Editors-in-Chief
Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA
Trending articles
Click here to view which articles have been shared the most in the last month.
First Author Profiles
Meet this month's featured authors!
Aims and scope
Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Prognostic factors for progression of osteoarthritis of the hip: a systematic review
The hip is the third joint most commonly affected by osteoarthritis (OA) and with no therapeutic cure for hip OA, predicting which patients with hip OA are more likely to show disease progression is important for healthcare professionals.
In this systematic review, Teirlinck et al assess the existing evidence of patient, health, and diagnostic variables associated with the progression in patients with hip osteoarthritis.
Follow
Annual Journal Metrics
-
Speed
62 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
131 days from submission to acceptance
25 days from acceptance to publicationCitation Impact
4.103 - 2-year Impact Factor
4.686 - 5-year Impact Factor
1.297 - Source Normalized Impact per Paper (SNIP)
1.684 - SCImago Journal Rank (SJR)Usage
2,048,553 Downloads
1,356 Altmetric mentions
